Literature DB >> 14962580

A timely re-examination of drug polymorphism in pharmaceutical development and regulation.

David J W Grant1, Stephen R Byrn.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14962580     DOI： 10.1016/j.addr.2003.12.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


× No keyword cloud information.
  3 in total

1.  Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation.

Authors:  Sari Airaksinen; Milja Karjalainen; Niina Kivikero; Sari Westermarck; Anna Shevchenko; Jukka Rantanen; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2005-10-06       Impact factor: 3.246

2.  Non-isothermal dehydration kinetic study of aspartame hemihydrate using DSC, TGA and DSC-FTIR microspectroscopy.

Authors:  Wei-Hsien Hsieh; Wen-Ting Cheng; Ling-Chun Chen; Shan-Yang Lin
Journal:  Asian J Pharm Sci       Date:  2017-12-08       Impact factor: 6.598

3.  Raman spectroscopy coupled with principal component analysis to quantitatively analyze four crystallographic phases of explosive CL-20.

Authors:  Xuan He; Yu Liu; Shiliang Huang; Yi Liu; Xuemei Pu; Tao Xu
Journal:  RSC Adv       Date:  2018-06-27       Impact factor: 3.361
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.